These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33592502)

  • 21. Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.
    Periyasamy M; Singh AK; Gemma C; Farzan R; Allsopp RC; Shaw JA; Charmsaz S; Young LS; Cunnea P; Coombes RC; Győrffy B; Buluwela L; Ali S
    Oncogene; 2021 Feb; 40(6):1077-1090. PubMed ID: 33323971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC3A is a prominent cytidine deaminase in breast cancer.
    Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
    PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.
    Xiao X; Yang H; Arutiunian V; Fang Y; Besse G; Morimoto C; Zirkle B; Chen XS
    Nucleic Acids Res; 2017 Jul; 45(12):7494-7506. PubMed ID: 28575276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B.
    Chen Y; Shen B; Zheng X; Long Q; Xia J; Huang Y; Cai X; Wang D; Chen J; Tang N; Huang A; Hu Y
    Emerg Microbes Infect; 2020; 9(1):366-377. PubMed ID: 32056513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
    Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
    J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.
    Roelofs PA; Goh CY; Chua BH; Jarvis MC; Stewart TA; McCann JL; McDougle RM; Carpenter MA; Martens JW; Span PN; Kappei D; Harris RS
    Elife; 2020 Sep; 9():. PubMed ID: 32985974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
    Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
    Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.
    Zhang W; Zhang X; Tian C; Wang T; Sarkis PT; Fang Y; Zheng S; Yu XF; Xu R
    Cell Microbiol; 2008 Jan; 10(1):112-21. PubMed ID: 17672864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G
    Yockteng-Melgar J; Shire K; Cheng AZ; Malik-Soni N; Harris RS; Frappier L
    J Virol; 2022 Sep; 96(18):e0066022. PubMed ID: 36069545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity.
    Rouf Banday A; Onabajo OO; Lin SH; Obajemu A; Vargas JM; Delviks-Frankenberry KA; Lamy P; Bayanjargal A; Zettelmeyer C; Florez-Vargas O; Pathak VK; Dyrskjøt L; Prokunina-Olsson L
    Commun Biol; 2021 Mar; 4(1):386. PubMed ID: 33753867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase.
    Serebrenik AA; Starrett GJ; Leenen S; Jarvis MC; Shaban NM; Salamango DJ; Nilsen H; Brown WL; Harris RS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22158-22163. PubMed ID: 31611371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.
    Argyris PP; Wilkinson PE; Jarvis MC; Magliocca KR; Patel MR; Vogel RI; Gopalakrishnan R; Koutlas IG; Harris RS
    Mod Pathol; 2021 Feb; 34(2):280-290. PubMed ID: 32632179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
    Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
    Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.
    Mori S; Takeuchi T; Ishii Y; Kukimoto I
    Biochem Biophys Res Commun; 2015 May; 460(3):555-60. PubMed ID: 25800874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
    Cescon DW; Haibe-Kains B; Mak TW
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
    Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
    Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
    Chou WC; Chen WT; Hsiung CN; Hu LY; Yu JC; Hsu HM; Shen CY
    Sci Rep; 2017 Mar; 7():44089. PubMed ID: 28276478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.